1. Home
  2. VANI vs BRID Comparison

VANI vs BRID Comparison

Compare VANI & BRID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • BRID
  • Stock Information
  • Founded
  • VANI 1998
  • BRID 1932
  • Country
  • VANI United States
  • BRID United States
  • Employees
  • VANI N/A
  • BRID N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BRID Specialty Foods
  • Sector
  • VANI Health Care
  • BRID Consumer Staples
  • Exchange
  • VANI Nasdaq
  • BRID Nasdaq
  • Market Cap
  • VANI 68.1M
  • BRID 70.3M
  • IPO Year
  • VANI 2014
  • BRID N/A
  • Fundamental
  • Price
  • VANI $1.15
  • BRID $7.65
  • Analyst Decision
  • VANI Strong Buy
  • BRID
  • Analyst Count
  • VANI 1
  • BRID 0
  • Target Price
  • VANI $4.00
  • BRID N/A
  • AVG Volume (30 Days)
  • VANI 136.2K
  • BRID 1.9K
  • Earning Date
  • VANI 08-12-2025
  • BRID 06-02-2025
  • Dividend Yield
  • VANI N/A
  • BRID N/A
  • EPS Growth
  • VANI N/A
  • BRID N/A
  • EPS
  • VANI N/A
  • BRID N/A
  • Revenue
  • VANI N/A
  • BRID $224,673,000.00
  • Revenue This Year
  • VANI N/A
  • BRID N/A
  • Revenue Next Year
  • VANI N/A
  • BRID N/A
  • P/E Ratio
  • VANI N/A
  • BRID N/A
  • Revenue Growth
  • VANI N/A
  • BRID N/A
  • 52 Week Low
  • VANI $0.91
  • BRID $7.52
  • 52 Week High
  • VANI $1.50
  • BRID $14.69
  • Technical
  • Relative Strength Index (RSI)
  • VANI 54.56
  • BRID 40.57
  • Support Level
  • VANI $1.13
  • BRID $7.64
  • Resistance Level
  • VANI $1.25
  • BRID $7.88
  • Average True Range (ATR)
  • VANI 0.05
  • BRID 0.17
  • MACD
  • VANI -0.01
  • BRID -0.01
  • Stochastic Oscillator
  • VANI 29.05
  • BRID 6.38

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

Share on Social Networks: